Dialysis
Covidien wins FDA nod for Fortrex PTA balloon catheter
DaVita, Medtronic to study arrhythmia in dialysis patients
Medtronic: Hemodialysis patients at risk for arrhythmia
NxStage study highlights advantages of home hemodialysis
Press Release: NxStage announces FDA clearance of Single Needle Technology
LAWRENCE, Mass. —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.
NxStage Medical’s single-needle home dialysis system comes to the U.S.
Massachusetts-based dialysis devices maker NxStage Medical (NSDQ:NXTM) won FDA clearance for its OneSite technology, cutting down on the number of needles dialysis patients must endure during therapy.
Baxter adds 200 jobs in Alabama expansion
Baxter recalls dialysis solution over contamination concerns
Medtronic opens hemodialysis plant in China
Flow Forward emerges from Novita incubator with vascular access tech
Early state vascular devices maker Flow Forward emerged from the nest, so to speak, spinning out of the Novita life sciences incubator in Olathe, Kansas.
Founded in 2011, Flow Forward is taking with it the AFE System, a device intended to help more patients undergo hemodialysis via an arteriovenous fistula (AVF), the gold standard in vascular access sites.